| Not Yet Recruiting | Trastuzumab Deruxtecan + Stereotactic Radiosurgery (SRS) in HER2+ Breast Cancer Brain Metastases NCT07454668 | Baptist Health South Florida | Phase 1 |
| Not Yet Recruiting | Symptom Management and Survivorship Plus Coaching for Advanced Cancer Survivors and Their Caregivers NCT07415564 | University of Arizona | N/A |
| Recruiting | Stereotactic Body Radiotherapy vs Conventional Palliative Radiotherapy for Painful Non-Spine Bone Metastases NCT06391242 | Canadian Cancer Trials Group | Phase 3 |
| Not Yet Recruiting | VERIFY: Vedolizumab for the Prevention of Immune Checkpoint Inhibitor Related Diarrhea or Colitis in Patients NCT06337695 | University of Calgary | Phase 2 / Phase 3 |
| Completed | Telerehabilitation in Oncology Patients NCT04547634 | University of Malaga | N/A |
| Completed | Effects of Dexmedetomidine/Lidocaine/Intrathecal Morphine on Cancer Metastasis Biomarker After Colorectal Surg NCT05742438 | Samsung Medical Center | N/A |
| Completed | Evaluation of an Automated System to Culture Metastatic Patient Circulating Tumor Cells in Embryonated Chicken NCT05472532 | Hospices Civils de Lyon | N/A |
| Recruiting | The Italian Registry of Malnutrition in Oncology NCT06337019 | Fondazione IRCCS Policlinico San Matteo di Pavia | — |
| Active Not Recruiting | Web-based Support for Family Caregivers of Patients With Advanced Cancer NCT05785494 | Ersta Sköndal University College | N/A |
| Completed | The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors NCT05131815 | Cedars-Sinai Medical Center | N/A |
| Unknown | Determine Safety & Recommended Phase 2 Dosing of Zeaxanthin Alone or in Combination w/Pembrolizumab in Patient NCT05232409 | Valley Health System | Phase 1 |
| Active Not Recruiting | Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in T NCT05103358 | Aadi Bioscience, Inc. | Phase 2 |
| Unknown | Intratumoral CAN1012(Selective TLR7 Agonist) in Subjects With Solid Tumors NCT04987112 | CanWell Pharma Inc. | Phase 1 |
| Recruiting | UNC Childhood, Adolescent, and Young Adult Cancer Cohort NCT05096923 | UNC Lineberger Comprehensive Cancer Center | — |
| Recruiting | IlluminOss Photodynamic Bone Stabilization System for the Treatment of Impending and Actual Pelvis Fractures NCT04842266 | Massachusetts General Hospital | — |
| Unknown | Real Word European Registry of NTRK Fusions and Other Rare Actionable Fusions (TRacKING) NCT04921553 | Centre Leon Berard | — |
| Completed | Study of AK112 in the Treatment of Advanced Gynecological Tumors NCT04870177 | Akeso | Phase 2 |
| Unknown | Low-Level Laser Effects on Orthodontic Tooth Movement of Periodontally Compromised Patients. NCT05739838 | Faculty of Dental Medicine for Girls | N/A |
| Recruiting | Improving Public Cancer Care by Implementing Precision Medicine in Norway NCT04817956 | Oslo University Hospital | Phase 2 |
| Active Not Recruiting | Lay Coach-Led Early Palliative Care for Underserved Advanced Cancer Caregivers: The Project ENABLE Cornerstone NCT04318886 | University of Alabama at Birmingham | Phase 3 |
| Completed | Informational Meetings for Planning and Coordinating Treatment NCT04330833 | Indiana University | N/A |
| Completed | Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients NCT04604158 | Gillian Gresham | N/A |
| Terminated | A Basket Trial of an ERK1/2 Inhibitor (LY3214996) in Combination With Abemaciclib. NCT04534283 | Anita Turk | Phase 2 |
| Recruiting | An Open-Label Study of INV-1120 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With NCT04443088 | Shenzhen Ionova Life Sciences Co., Ltd. | Phase 1 |
| Active Not Recruiting | Endocrine Therapy With Abemaciclib or Chemotherapy as Initial Metastatic Treatment in ER+/HER2- Breast Cancer NCT04158362 | UNICANCER | Phase 3 |
| Completed | Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Gastric Carcinomatosis. Phase II Randomized Study NCT04065139 | Assistance Publique - Hôpitaux de Paris | Phase 2 |
| Completed | Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer NCT03993353 | University of California, San Diego | Phase 2 |
| Unknown | Colorectal Liver Metastases: Novel Assessment Tools for Technical Resectability NCT04270851 | University of Manchester | — |
| Unknown | Access to Single-Fraction Palliative Radiation Therapy in Cancer Patients Enrolled in Hospice NCT04049188 | Care Partners | N/A |
| Unknown | The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor NCT03896958 | SpeciCare | — |
| Active Not Recruiting | Digitally-Captured Step Counts for Evaluating Performance Status in Advanced Cancer Patients NCT03757182 | Cedars-Sinai Medical Center | — |
| Unknown | Phase I Study of SHR9146 + SHR-1210 +/- Apatinib in Patients With Advanced Solid Tumors NCT03491631 | Jiangsu HengRui Medicine Co., Ltd. | Phase 1 |
| Completed | An Upstream Palliative Care Intervention for Rural and African-American Advanced Cancer Family Caregivers NCT03464188 | University of Alabama at Birmingham | N/A |
| Unknown | Guided Imagery & Music in Cancer NCT03936075 | Aalborg University | N/A |
| Completed | Mindfulness for Pain Management in Patients With Cancer NCT03351010 | University of Michigan | N/A |
| Active Not Recruiting | Chemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer NCT03383094 | Loren Mell, MD | Phase 2 |
| Recruiting | SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry NCT03452774 | Massive Bio, Inc. | — |
| Active Not Recruiting | Muscle Dysfunction in Gastrointestinal or Hepatobiliary Cancer NCT03347162 | Rigshospitalet, Denmark | — |
| Unknown | Efficacy and Tolerability of Hemopatch After Hepatic Resection NCT03323359 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | N/A |
| Completed | Clinical and Functional Variables in Oncology NCT03879096 | University of Malaga | N/A |
| Terminated | A Combination of Pazopanib and Carboplatin in Advanced Solid Malignancies NCT01542047 | New Mexico Cancer Research Alliance | Phase 1 |